
2603 articles by Nicole Gray
-
PhRMA: US remains vaccine R&D leader
Aug. 19, 2016 -
Roche, Eleven Bio eye the ocular market
Aug. 19, 2016 -
Nutrinia raises $30M for pediatric oral insulin
Aug. 19, 2016 -
Chinese/Indian manufacturing facilities facing repercussions
Aug. 18, 2016 -
Another Indian API facility added to EU's 'do not import' list
Aug. 18, 2016 -
FDA expedites Aspen's prostate drug ahead of merger
Aug. 18, 2016 -
Trek Therapeutics in-licenses Medivir hep C drug
Aug. 18, 2016 -
Rasna Therapeutics taps public market with merger
Aug. 18, 2016 -
GSK enters pay-for-performance deal for gene therapy
Aug. 17, 2016 -
Ipsen hopes to be David to Allergan's Goliath
Aug. 17, 2016 -
JAMA: PCSK9s should cost $4536, but don't
Aug. 17, 2016 -
Chiasma slashes staff as problems persist
Aug. 16, 2016 -
Boehringer seeks real-world data to support reversal agent
Aug. 16, 2016 -
Cynapsus proceeds after safety OK
Aug. 16, 2016 -
Aurinia succeeds, but safety concerns loom
Aug. 16, 2016 -
Allergan to consolidate operations in NJ
Aug. 12, 2016 -
Mallinckrodt plans regen med acquisition
Aug. 12, 2016 -
Gilead licenses bi-specific tech from Danish biotech Genmab
Aug. 12, 2016 -
Spark Therapeutics on track to file gene therapy in 2017
Aug. 11, 2016 -
Medivation bullish on Xtandi as PDUFA approaches
Aug. 11, 2016 -
AstraZeneca bolsters stake in Moderna by $140 million
Aug. 11, 2016 -
Shire launches new treatment for hereditary bleeding disorder
Aug. 10, 2016 -
AstraZeneca's lung cancer hopeful fails in Phase 3
Aug. 10, 2016 -
Novartis execs indicted in bribery scandal—this time in Korea
Aug. 10, 2016 -
BIO president defends Orphan Drug Act after op-ed criticism
Aug. 9, 2016